Our research is focused on: 1. Identifying genetic markers for chemotherapy induced adverse drug reactions 2. the toxicity of new psychoactive substances & how to use post-mortem metabolomics. We develop prediction models using massive parallel sequencing, single cell RNASeq & high resolution chromatin conformation capture and bioinformatics with large clinical cohorts. In forensics, we develop new techniques using the CBRS platform for neuropharmacology as well as post-mortem metabolomics.
Henrik Green
Linköping University
Key Publications
In vitro metabolomics for the characterization of drugs of abuse and new psychoactive substances in SH-SY5Y cells
Environmental Toxicology and Pharmacology, 2026
Human-to-Rat Validation of PMI Biomarkers: A Bidirectional Cross-Species Metabolomics Study Reveals Asymmetric Translation
Analytical Chemistry, 2026
5‐HT2A receptor agonism by tert‐leucinamide and valinamide synthetic cannabinoids: In vitro and in vivo evidence
British Journal of Pharmacology, 2026
Development and analytical validation of a targeted short‐read next generation sequencing‐based pharmacogenetic panel for comprehensive variant detection
British Journal of Pharmacology, 2026
Fatal intoxications with nitazenes: postmortem findings, toxicology, and in vitro characterization at the μ-opioid receptor of six nitazene analogues
Archives of Toxicology, 2026